Michael A Metzger Syndax Pharmaceuticals Inc (SNDX) insider trading activity

Michael A Metzger is Chief Executive Officer of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 306,195 shares of SNDX, which is worth approximately $4.04 Million. The most recent transaction as insider was on Nov 04, 2020, when has been sold 100,000 shares (Common Stock) at a price of $20.31 per share, resulting in proceeds of $2,031,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 306K

86.81% 3M change

86.81% 12M change

Total Value Held $4.04 Million

Michael A Metzger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 04 2020	SELL Open market or private sale	$2,031,000 $20.31 p/Share	100,000 Reduced 84.99%	17,659 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$720,000 $7.2 p/Share	100,000 Added 45.94%	117,659 Common Stock

Also insider at

CTIC

CTI BIOPHARMA CORP Healthcare

Director

PYXS

Pyxis Oncology, Inc. Healthcare

MAM